rash from tirzepatide shot Mounjaro Injection Site Rash: Causes & Management 💉 What to do if

Robert Lustig, MD: How are you going to do that

Many get lost or tired before they arrive

(they're the same thing)

Retatrutide trials have reported gastrointestinal adverse effects including nausea, vomiting, diarrhoea, and reduced appetite particularly during dose escalation phases

Most recent formulary updates reviewed: January 2026 Government Programs: What's Changing NEW: TrumpRx.gov (Launched Feb 2026) TrumpRx.gov launched February 6, 2026, offering GLP-1 medications at negotiated pricesavailable to all Americans , regardless of insurance status: Average price: ~$346/month (down from ~$1,086 retail) Who can use it: Anyonenot limited to Medicare/Medicaid Best for: Medicare patients (until July 2026 bridge program), uninsured, or those with non-covering plans NEW: CMS BALANCE Model (Announced Dec 2025) On December 23, 2025, CMS launched the BALANCE Model (Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth)a voluntary pilot program to expand GLP-1 access through negotiated pricing: [7] Medicaid: States can join on a rolling basis from May 2026 through December 2026 Medicare Part D: Expanded access begins January 2027 Medicare bridge demo: Starting July 2026, eligible beneficiaries may access GLP-1s at a fixed $50/month cost outside standard Part D benefits How it works: CMS negotiates directly with manufacturers for lower net prices